Down regulation of NM23.H1, NM23.H2 and c-myc genes during differentiation induced by 1,25 dihydroxyvitamin D3
- 1 February 1996
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 20 (2) , 161-167
- https://doi.org/10.1016/0145-2126(95)00122-0
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- NM23 gene expression correlates with cell growth rate and S‐phaseInternational Journal of Cancer, 1995
- Reorganization of the cytoskeleton and morphological changes induced by 1,25-dihydroxyvitamin D3 in C3H/10T1/2 mouse embryo fibroblasts: Relation to inhibition of proliferationExperimental Cell Research, 1992
- myc FUNCTION AND REGULATIONAnnual Review of Biochemistry, 1992
- Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinaseBiochemical and Biophysical Research Communications, 1992
- The Role of the Vitamin D Endocrine System in Health and DiseaseNew England Journal of Medicine, 1989
- Possible involvement of 1α,25-dihydroxyvitamine D3 in proliferation and differentiation of 3T3-L1 cellsBiochemical and Biophysical Research Communications, 1988
- 1,25-Dihydroxyvitamin D3 induces collagen binding to the human monocyte line U937.Journal of Clinical Investigation, 1987
- Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells.Journal of Clinical Investigation, 1986
- Phenotypic differentiation-linked growth inhibition in human leukemia cells by active vitamin D3 analoguesInternational Journal of Cancer, 1984
- Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metaboliteNature, 1983